<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36354180</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1948-7185</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>45</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>The journal of physical chemistry letters</Title><ISOAbbreviation>J Phys Chem Lett</ISOAbbreviation></Journal><ArticleTitle>Moderate Binding between Two SARS-CoV-2 Protein Segments and &#x3b1;-Synuclein Alters Its Toxic Oligomerization Propensity Differently.</ArticleTitle><Pagination><StartPage>10642</StartPage><EndPage>10648</EndPage><MedlinePgn>10642-10648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jpclett.2c02278</ELocationID><Abstract><AbstractText>The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain unclear. Here, we reported that the receptor-binding domain (RBD) of the spike protein and the nine-residue segment (SK9) of the envelope protein could bind to &#x3b1;-synuclein (&#x3b1;Syn) with <i>K</i><sub>d</sub> values of 503 &#xb1; 24 nM and 12.7 &#xb1; 1.6 &#x3bc;M, respectively. RBD could inhibit &#x3b1;Syn fibrillization by blocking the non-amyloid-&#x3b2; component region and mediating its antiparallel &#x3b2;-sheet structural conversions. Omicron-RBD (BA.5) was shown to have a slightly stronger affinity for &#x3b1;Syn (<i>K</i><sub>d</sub> = 235 &#xb1; 10 nM), which implies similar effects, whereas SK9 may bind to the C-terminus which accelerates the formation of parallel &#x3b2;-sheet-containing oligomers and abruptly increases the rate of membrane disruption by 213%. Our results provide plausible molecular insights into the impact of SARS-CoV-2 post-infection and the oligomerization propensity of &#x3b1;Syn that is associated with Parkinson's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mesias</LastName><ForeName>Vince St Dollente</ForeName><Initials>VSD</Initials><Identifier Source="ORCID">0000-0002-6206-8014</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hongni</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5294-7963</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yusong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jinqing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6865-8528</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Phys Chem Lett</MedlineTA><NlmUniqueID>101526034</NlmUniqueID><ISSNLinking>1948-7185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705509">envelope protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086968">Coronavirus Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="Y">alpha-Synuclein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086968" MajorTopicYN="Y">Coronavirus Envelope Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36354180</ArticleId><ArticleId IdType="pmc">PMC9662073</ArticleId><ArticleId IdType="doi">10.1021/acs.jpclett.2c02278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . COVID-19 Weekly Epidemiological Update. 2022, No. June, 1&#x2013;33.</Citation></Reference><Reference><Citation>Karim S. S. A.; Karim Q. A. Omicron SARS-CoV-2 Variant: A New Chapter in the COVID-19 Pandemic. Lancet 2021, 398 (10317), 2126&#x2013;2128. 10.1016/S0140-6736(21)02758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V.; Rodr&#xed;guez-Violante M.; Abundes A.; Rukavina K.; Teo J. T.; Falup-Pecurariu C.; Irincu L.; Rota S.; Bhidayasiri R.; Storch A.; Odin P.; Antonini A.; Ray Chaudhuri K. Parkinson&#x2019;s Disease and Post&#x2013;COVID-19 Syndrome: The Parkinson&#x2019;s Long-COVID Spectrum. Mov. Disord. 2021, 36 (6), 1287&#x2013;1289. 10.1002/mds.28622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28622</ArticleId><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="pubmed">33890344</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao A. R.; Hidayathullah S. M.; Hegde K.; Adhikari P. Parkinsonism: An Emerging Post COVID Sequelae. IDCases 2022, 27, e0138810.1016/j.idcr.2022.e01388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2022.e01388</ArticleId><ArticleId IdType="pmc">PMC8733235</ArticleId><ArticleId IdType="pubmed">35018281</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider S. A.; Hennig A.; Martino D. Relationship between COVID-19 and Movement Disorders: A Narrative Review. Eur. J. Neurol. 2022, 29 (4), 1243&#x2013;1253. 10.1111/ene.15217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15217</ArticleId><ArticleId IdType="pubmed">34918437</ArticleId></ArticleIdList></Reference><Reference><Citation>Makhoul K.; Jankovic J. Parkinson&#x2019;s Disease after COVID-19. J. Neurol. Sci. 2021, 422, 117331.10.1016/j.jns.2021.117331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117331</ArticleId><ArticleId IdType="pmc">PMC9755718</ArticleId><ArticleId IdType="pubmed">33540185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I.; Mayer M. G.; Hellmers L. M.; Ning B.; Huang Z.; Monjure C. J.; Coyne C.; Silvestri R.; Golden N.; Hensley K.; Chandler K.; Lehmicke G.; Bix G. J.; Maness N. J.; Russell-Lodrigue K.; Hu T. Y.; Roy C. J.; Blair R. V.; Bohm R.; Doyle-Meyers L. A.; Rappaport J.; Fischer T. Neuropathology and Virus in Brain of SARS-CoV-2 Infected Non-Human Primates. Nat. Commun. 2022, 13 (1), 1745.10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe A.; Pietropaoli S.; Vos M.; Barba-Spaeth G.; Zurzolo C. Tunneling Nanotubes Provide a Novel Route for SARS-CoV-2 Spreading between Permissive Cells and to Non-Permissive Neuronal Cells. Sci. Adv. 2022, 8 (29), eabo017110.1126/sciadv.abo0171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abo0171</ArticleId><ArticleId IdType="pmc">PMC9299553</ArticleId><ArticleId IdType="pubmed">35857849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukerji S. S.; Solomon I. H. What Can We Learn from Brain Autopsies in COVID-19?. Neurosci. Lett. 2021, 742, 135528.10.1016/j.neulet.2020.135528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135528</ArticleId><ArticleId IdType="pmc">PMC7687409</ArticleId><ArticleId IdType="pubmed">33248159</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P.; Kratzel A.; Steiner S.; Stalder H.; Thiel V. Coronavirus Biology and Replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021, 19 (3), 155&#x2013;170. 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. B.; Farzan M.; Chen B.; Choe H. Mechanisms of SARS-CoV-2 Entry into Cells. Nat. Rev. Mol. Cell Biol. 2022, 23 (1), 3&#x2013;20. 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S.; Hammarstr&#xf6;m P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J. Am. Chem. Soc. 2022, 144 (20), 8945&#x2013;8950. 10.1021/jacs.2c03925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E. M.; Logsdon A. F.; Hansen K. M.; Williams L. M.; Reed M. J.; Baumann K. K.; Holden S. J.; Raber J.; Banks W. A.; Erickson M. A. The S1 Protein of SARS-CoV-2 Crosses the Blood&#x2013;Brain Barrier in Mice. Nat. Neurosci. 2021, 24 (3), 368&#x2013;378. 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo M. P.; Iba M.; Nath A.; Masliah E.; Kim C. Does SARS-CoV-2 Affect Neurodegenerative Disorders? TLR2, a Potential Receptor for SARS-CoV-2 in the CNS. Exp. Mol. Med. 2022, 54 (4), 447&#x2013;454. 10.1038/s12276-022-00755-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00755-7</ArticleId><ArticleId IdType="pmc">PMC8990637</ArticleId><ArticleId IdType="pubmed">35396576</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T. P.; DeOre B. J.; Baldwin-Leclair A.; Bullock T. A.; McGary H. M.; Khan J. A.; Razmpour R.; Hale J. F.; Galie P. A.; Potula R.; Andrews A. M.; Ramirez S. H. The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood&#x2013;Brain Barrier. Neurobiol. Dis. 2020, 146, 105131.10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.; Su Y.; Zhou Y.; Wei H.; Xu Q. The SARS-CoV-2 Envelope Protein Disrupts Barrier Function in an in Vitro Human Blood-Brain Barrier Model. Front. Cell. Neurosci. 2022, 16, 897564.10.3389/fncel.2022.897564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.897564</ArticleId><ArticleId IdType="pmc">PMC9445123</ArticleId><ArticleId IdType="pubmed">36082238</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatman E. L.; Massey A.; Shives K. D.; Burrack K. S.; Chamanian M.; Morrison T. E.; Beckham J. D. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain. J. Virol. 2016, 90 (6), 2767&#x2013;2782. 10.1128/JVI.02949-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02949-15</ArticleId><ArticleId IdType="pmc">PMC4810656</ArticleId><ArticleId IdType="pubmed">26719256</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L. A-Synuclein in Parkinson's Disease. Cold Spring Harbor Perspect. Med. 2012, 2 (2), a009399.10.1101/cshperspect.a009399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a009399</ArticleId><ArticleId IdType="pmc">PMC3281589</ArticleId><ArticleId IdType="pubmed">22355802</ArticleId></ArticleIdList></Reference><Reference><Citation>Meade R. M.; Fairlie D. P.; Mason J. M. Alpha-Synuclein Structure and Parkinson&#x2019;s Disease - Lessons and Emerging Principles. Mol. Neurodegener. 2019, 14 (1), 29.10.1186/s13024-019-0329-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0329-1</ArticleId><ArticleId IdType="pmc">PMC6647174</ArticleId><ArticleId IdType="pubmed">31331359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoly O.; Safavi F.; Tavassoly I. Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection. ACS Chem. Neurosci. 2020, 11 (22), 3704&#x2013;3706. 10.1021/acschemneuro.0c00676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00676</ArticleId><ArticleId IdType="pubmed">33147014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J.; Ye G.; Shi K.; Wan Y.; Luo C.; Aihara H.; Geng Q.; Auerbach A.; Li F. Structural Basis of Receptor Recognition by SARS-CoV-2. Nature 2020, 581 (7807), 221&#x2013;224. 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D.; Kumar V. SARS-CoV-2 Spike Protein Interactions with Amyloidogenic Proteins: Potential Clues to Neurodegeneration. Biochem. Biophys. Res. Commun. 2021, 554, 94&#x2013;98. 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Semerdzhiev S. A.; Fakhree M. A. A.; Segers-Nolten I.; Blum C.; Claessens M. M. A. E. Interactions between SARS-CoV-2 N-Protein and &#x3b1;-Synuclein Accelerate Amyloid Formation. ACS Chem. Neurosci. 2022, 13 (1), 143&#x2013;150. 10.1021/acschemneuro.1c00666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00666</ArticleId><ArticleId IdType="pmc">PMC8739828</ArticleId><ArticleId IdType="pubmed">34860005</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana A. K.; Greenwood A. B.; Hansmann U. H. E. Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A. J. Phys. Chem. B 2021, 125 (32), 9155&#x2013;9167. 10.1021/acs.jpcb.1c04871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c04871</ArticleId><ArticleId IdType="pmc">PMC8369982</ArticleId><ArticleId IdType="pubmed">34370466</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana A. K.; Lander C. W.; Chesney A. D.; Hansmann U. H. E. Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on &#x3b1;-Synuclein Monomers and Fibrils. J. Phys. Chem. B 2022, 126 (20), 3648&#x2013;3658. 10.1021/acs.jpcb.2c01254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.2c01254</ArticleId><ArticleId IdType="pmc">PMC9186263</ArticleId><ArticleId IdType="pubmed">35580331</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X.; Li Y.; Xia Y. L.; Ai S. M.; Liang J.; Sang P.; Ji X.-L.; Liu S.-Q. Insights into Protein&#x2013;Ligand Interactions Mechanisms, Models, and Methods. Int. J. Mol. Sci. 2016, 17 (2), 144.10.3390/ijms17020144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17020144</ArticleId><ArticleId IdType="pmc">PMC4783878</ArticleId><ArticleId IdType="pubmed">26821017</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield N. J. Using Circular Dichroism Spectra to Estimate Protein Secondary Structure. Nat. Protoc. 2006, 1 (6), 2876&#x2013;2890. 10.1038/nprot.2006.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.202</ArticleId><ArticleId IdType="pmc">PMC2728378</ArticleId><ArticleId IdType="pubmed">17406547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremades N.; Chen S. W.; Dobson C. M. Structural Characteristics of &#x3b1;-Synuclein Oligomers. Int. Rev. Cell Mol. Biol. 2017, 329, 79&#x2013;143. 10.1016/bs.ircmb.2016.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2016.08.010</ArticleId><ArticleId IdType="pubmed">28109332</ArticleId></ArticleIdList></Reference><Reference><Citation>Winner B.; Jappelli R.; Maji S. K.; Desplats P. A.; Boyer L.; Aigner S.; Hetzer C.; Loher T.; Vilar M.; Campioni S.; Tzitzilonis C.; Soragni A.; Jessberger S.; Mira H.; Consiglio A.; Pham E.; Masliah E.; Gage F. H.; Riek R. In Vivo Demonstration That &#x3b1;-Synuclein Oligomers Are Toxic. Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (10), 4194&#x2013;4199. 10.1073/pnas.1100976108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100976108</ArticleId><ArticleId IdType="pmc">PMC3053976</ArticleId><ArticleId IdType="pubmed">21325059</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens A. D.; Zacharopoulou M.; Moons R.; Fusco G.; Seetaloo N.; Chiki A.; Woodhams P. J.; Mela I.; Lashuel H. A.; Phillips J. J.; De Simone A.; Sobott F.; Schierle G. S. K. Extent of N-Terminus Exposure of Monomeric Alpha-Synuclein Determines Its Aggregation Propensity. Nat. Commun. 2020, 11 (1), 2820.10.1038/s41467-020-16564-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16564-3</ArticleId><ArticleId IdType="pmc">PMC7272411</ArticleId><ArticleId IdType="pubmed">32499486</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>